953 related articles for article (PubMed ID: 27131827)
1. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
[TBL] [Abstract][Full Text] [Related]
2. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
3. Arctigenin Attenuates Learning and Memory Deficits through PI3k/Akt/GSK-3β Pathway Reducing Tau Hyperphosphorylation in Aβ-Induced AD Mice.
Qi Y; Dou DQ; Jiang H; Zhang BB; Qin WY; Kang K; Zhang N; Jia D
Planta Med; 2017 Jan; 83(1-02):51-56. PubMed ID: 27224270
[TBL] [Abstract][Full Text] [Related]
4. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS
Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037
[TBL] [Abstract][Full Text] [Related]
5. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β.
Zhou M; Chen S; Peng P; Gu Z; Yu J; Zhao G; Deng Y
Biochem Biophys Res Commun; 2019 Mar; 511(1):154-160. PubMed ID: 30773255
[TBL] [Abstract][Full Text] [Related]
6. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N
J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity.
Jantrapirom S; Nimlamool W; Chattipakorn N; Chattipakorn S; Temviriyanukul P; Inthachat W; Govitrapong P; Potikanond S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138327
[TBL] [Abstract][Full Text] [Related]
8. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.
Ali T; Kim MO
J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697
[TBL] [Abstract][Full Text] [Related]
9. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
11. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo.
Kim HG; Park G; Lim S; Park H; Choi JG; Jeong HU; Kang MS; Lee MK; Oh MS
J Ethnopharmacol; 2015 Aug; 171():196-204. PubMed ID: 26068423
[TBL] [Abstract][Full Text] [Related]
12. The seed of
Sun Y; Wu A; Li X; Qin D; Jin B; Liu J; Tang Y; Wu J; Yu C
Pharm Biol; 2020 Dec; 58(1):35-43. PubMed ID: 31881157
[No Abstract] [Full Text] [Related]
13. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
[TBL] [Abstract][Full Text] [Related]
14. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
15. Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling.
Shu X; Zhang Y; Li M; Huang X; Yang Y; Zeng J; Zhao Y; Wang X; Zhang W; Ying Y
Neuropharmacology; 2019 Jul; 153():1-12. PubMed ID: 31015047
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice.
Chen S; Sun J; Zhao G; Guo A; Chen Y; Fu R; Deng Y
Neurochem Res; 2017 Aug; 42(8):2326-2335. PubMed ID: 28382596
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3β.
Qi L; Chen Z; Wang Y; Liu X; Liu X; Ke L; Zheng Z; Lin X; Zhou Y; Wu L; Liu L
Am J Transl Res; 2017; 9(2):247-260. PubMed ID: 28337257
[TBL] [Abstract][Full Text] [Related]
19. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
Chen Y; Chen Y; Liang Y; Chen H; Ji X; Huang M
Biomed Pharmacother; 2020 Jan; 121():109670. PubMed ID: 31810131
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway.
Wang YJ; Ren QG; Gong WG; Wu D; Tang X; Li XL; Wu FF; Bai F; Xu L; Zhang ZJ
Oncotarget; 2016 Mar; 7(12):13328-39. PubMed ID: 26950279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]